Miltenyi Biotec at the AACR Annual Meeting 2021

Miltenyi Biotec at the AACR Annual Meeting 2021

April 10–15, 2021 | May 17–21, 2021

Take your cancer research to the next level

Every year, the AACR Annual Meeting is an enormous event featuring insights into ground-breaking developments and advancements in cancer research. Also this year, we are pleased to contribute to the meeting with our Spotlight Theater presenting two scientific talks on how cancer researchers use single-cell sequencing and high-content imaging to drive immuno-oncology biomarker discovery.

At Miltenyi Biotec, we are committed to support researchers with cutting-edge technologies and combine them to whole workflow solutions, comprising solid tumor dissociation, cell isolation, cell analysis, cell culture, and high-content and light sheet microscopy. Check out this web page and get inspired by the vast variety of applications and products for your cancer research.


Spotlight Theater

Understand tumor complexity – deep phenotyping at single-cell level

Join our spotlight theater to get insights into how our customers unravel the complexity of tumors using single-cell genomics and high-content imaging thus driving the discovery of immuno-oncology biomarkers from tumor patient samples. 

Only participants of the virtual AACR Annual Meeting 2021 can access the Spotlight Theater through the event platform. Not registered yet? Register here.


Monday, April 12, 2021
11:00 a.m.–12:00 p.m. EST
Talk: Discover immuno-oncology 
biomarkers with single-cell genomics
Mayra Carneiro, M.Sc.
CHUM Research Centre, 
Laboratory of immuno-oncology, 
Montréal, Canada
Talk: The MACSima™ Imaging Platform – the only complete solution for ultrahigh-content imaging
Yvonne Dürnberger, Ph.D. 
Miltenyi Biotec, Germany
Talk: Immunological profiling 
of cancer by ultrahigh-content imaging
Christian Seitz, M.D.
University Children's Hospital,
Tübingen, Germany






Genomics applications

Cell preparation for improved genomic analysis

By improving the quality of your starting material you can greatly increase the reliability of your single-cell genomics and NGS results. Regardless of the type of cellular samples you work with, we provide you with gentle and automated workflow solutions to improve your data quality. 

Improve your genomics

Drug discovery applications

Automated cell-based assays in drug discovery and development

At Miltenyi Biotec, we strive to move drug discovery and development research forward. Our wide-ranging portfolio of automated instruments for cellular and drug safety assays, as well as extensive options of reagents, give users the first-rate support they need to base their research on reliable solutions to ensure high-quality standards.

Discover more


icon Resources

Contact us

Do you want to get in contact with us? Send your inquiry to:

Jana Soyka, Ph.D. 
Global Product Manager and Group Leader – Cancer Research

Seems like you are coming from USA!
Do you want to visit our website in your country?